HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Paul Castaigne Selected Research

ANG 1009

4/2010New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Paul Castaigne Research Topics

Disease

2Brain Neoplasms (Brain Tumor)
01/2015 - 04/2010
2Neoplasms (Cancer)
01/2015 - 04/2010
2Pain (Aches)
03/2014 - 05/2006
1Breast Ductal Carcinoma
01/2015
1Breast Neoplasms (Breast Cancer)
01/2015
1Chronic Pain
03/2014
1Bone Neoplasms (Bone Cancer)
03/2014
1Brain Diseases (Brain Disorder)
12/2010
1Postherpetic Neuralgia
05/2006
1Body Weight (Weight, Body)
03/2003

Drug/Important Bio-Agent (IBA)

1ANG4043IBA
01/2015
1Peptides (Polypeptides)IBA
01/2015
1Monoclonal AntibodiesIBA
01/2015
1ANG2002IBA
03/2014
1Analgesics (Analgesic Drugs)IBA
03/2014
1Formaldehyde (Formol)FDA Link
03/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2010
1Biological ProductsIBA
04/2010
1ANG 1007IBA
04/2010
1Etoposide (VP 16)FDA LinkGeneric
04/2010
1ANG 1009IBA
04/2010
1Opioid Analgesics (Opioids)IBA
05/2006
1Acetaminophen (Paracetamol)FDA LinkGeneric
05/2006
1Glucose (Dextrose)FDA LinkGeneric
03/2003
1CJC 1131IBA
03/2003

Therapy/Procedure

2Analgesia
03/2014 - 05/2006
1Therapeutics
12/2010